Afya VP sells 36,204 shares at $15 each

Afya Ltd vice president Junior Lelio de Souza reported an open-market sale of 36,204 Class A Common Shares on July 1, 2026.

Accepted by SEC EDGAR 07/06/2026 - 04:55 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Afya Ltd vice president Junior Lelio de Souza reported an open-market sale of 36,204 Class A Common Shares on July 1, 2026. The shares were sold at a price of $15.00 per share. Following this transaction, he reported owning no Class A Common Shares directly.

Insider Trade Summary

Net Seller: 36,204 shares

Net Sell 1 txn

Insider Junior Lelio de Souza

Role Vice President

Sold 36,204 shs ($543K)

Type	Security	Shares	Price	Value
Sale	Class A Common Share	36,204	$15.00	$543K

Holdings After Transaction: Class A Common Share — 0 shares (Direct)

Key Figures

Shares sold: 36,204 shares Sale price: $15.00 per share Shares after transaction: 0 shares +2 more

5 metrics

Shares sold 36,204 shares Class A Common Shares sold on July 1, 2026

Sale price $15.00 per share Price for the Class A Common Share sale

Shares after transaction 0 shares Total Class A Common Shares directly owned after sale

Net shares sold 36,204 shares Net-sell direction in transaction summary

Sell transactions count 1 transaction Number of sale transactions reported

Key Terms

Class A Common Share, open-market sale, Form 4, transaction code "S"

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code "S" financial

"transaction_code: "S" described as sale"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Afya (AFYA) report for Junior Lelio de Souza?

Afya vice president Junior Lelio de Souza reported selling 36,204 Class A Common Shares in an open-market transaction. The sale occurred on July 1, 2026, and was disclosed in a Form 4 insider trading report filed with the SEC.

How many Afya (AFYA) shares did the vice president sell and at what price?

The vice president sold 36,204 Afya Class A Common Shares at a price of $15.00 per share. This was a single reported open-market sale transaction, according to the Form 4 insider filing data provided.

What are Junior Lelio de Souza’s Afya (AFYA) holdings after this Form 4 sale?

After the reported transaction, Junior Lelio de Souza’s direct holdings of Afya Class A Common Shares were listed as zero. The Form 4 shows total shares following the transaction of 0.0000, indicating no remaining directly owned shares.

Was the Afya (AFYA) insider transaction an open-market sale or another type?

The transaction was characterized as an open-market sale of Class A Common Shares. The Form 4 lists transaction code “S” and describes it as a sale in an open market or private transaction, confirming it as a sell-side trade.

Did the Afya (AFYA) Form 4 include any derivative securities for the vice president?

The Form 4 data shows no derivative transactions or remaining derivative positions for the vice president. The derivativeSummary is empty and derivativeTransactionCount is zero, indicating only a non-derivative common share sale was reported.

How many Afya (AFYA) shares did insiders in this Form 4 buy or sell in total?

The insider filing shows total sell transactions of 36,204 shares and no purchases. The transactionSummary indicates one sale transaction, zero buy transactions, and a net-sell direction of 36,204 shares for the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Junior Lelio de Souza

(Last)

(First)

(Middle)

C/O AFYA LIMITED

RUA PARAIBA NO.330 17TH FL, FUNCIONARIOS

(Street)

BELO HORIZONTE

MINAS GERAIS

30130-917

(City)

(State)

(Zip)

BRAZIL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Afya Ltd [ AFYA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Share	07/01/2026		S		36,204	D	$15	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Lelio de Souza Junior	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR